Antoinette Gomes, MD, FAHA, FSIR

Antoinette S. Gomes, MD, FAHA, FSIR

Professor, Departments of Medicine and Radiology, Radiological Sciences




Diagnostic Radiology, Interventional Radiology

Institutional Affiliation

Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica



Cardiovascular Radiology, University of Minnesota GME, 1976 - 1978
Cardiology, UCLA School of Medicine, 1975 - 1976


Internal Medicine, LAC + USC Medical Center, 1969 - 1970


MD, Medical College of Pennsylvania c/o Drexel University, 1969


Radiological Sciences, Stanford University School of Medicine, 1972 - 1975
Internal Medicine, LAC + USC Medical Center, 1970 - 1972

Board Certification

Interventional Radiology and Diagnostic Radiology, American Board of Radiology, 2017

Contact Information

Clinical Interests

Angioplasty, Arteriovenous Malformations (AVM), AV Fistula, Chemoembolization, Clot Dissolving, Covered Stents, Embolization, Esophageal Varices, Excessive Menstrual Bleeding, Hemangioma, Liver Cancer, Liver Failure, Menorrhagia, Stents, Thrombectomy, Thrombolysis, Transjugular Intrahepatic Portosystemic Shunt (TIPS), Uterine Fibroid Embolization (UFE), Venous Malformation

Scientific Interests

Dr. Antoinette Gomes' research interests include:

  1. Locoregional treatment of primary and secondary liver cancer (hepatocellular carcinoma, colorectal, neuroendocrine, etc.);
  2. Uterine cancer and benign tumors of the uterus; and
  3. Angiosarcoma and benign tumors and malformations of the vascular system.

Highlighted Publications

Gomes AS, Monteleone PA, Sayre JW, Finn RS, Sadeghi S, Tong MJ, Britten CD, Busuttil RW. Comparison of Triple-Drug Transcatheter Arterial Chemoembolization (TACE) With Single-Drug TACE Using Doxorubicin-Eluting Beads: Long-Term Survival in 313 Patients. AJR Am J Roentgenol. 2017 Oct;209(4):722-732. doi: 10.2214/AJR.17.18219. Epub 2017 Jul 13.

Britten CD, Gomes AS, Wainberg ZA, Elashoff D, Amado R, Xin Y, Busuttil RW, Slamon DJ, Finn RS. Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: a pilot study. BMC Cancer. 2012 Jan 14;12:16. doi: 10.1186/1471-2407-12-16.

Gomes AS, Rosove MH, Rosen PJ, Amado RG, Sayre JW, Monteleone PA, Busuttil RW. Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients. AJR Am J Roentgenol. 2009 Dec;193(6):1665-71. doi: 10.2214/AJR.08.1806.